Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldValence Discovery
Categories
foundation-modelshealthcare
HQMontreal, Canada
Founded2018
Latest valuation—
Annual Recurring Revenue (ARR)—
Funding to date$8.5M
Headcount—
Profitability—
Statusactive
Pricing tierenterprise
DescriptionValence Discovery applies AI-driven generative chemistry to accelerate drug discovery for previously intractable biology targets. The platform uses few-shot learning and proprietary molecular representation techniques to enable rapid end-to-end design of novel chemical matter against complex disease targets.